Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Indacaterol

A long-acting beta-2 agonist bronchodilator, approved in Europe in 2009 and in the United States in 2011 for maintenance treatment of chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It was the first long-acting beta-2 agonist approved for a single inhalation a day: its bronchodilator effect covers the full 24 hours.

IndacaterolGo to the active ingredient →
IndacaterolActive ingredientIndacaterolCat. No. P-I037-001CAS 312753-06-3
Indacaterol-d3Isotopically labelledIndacaterol-d3Cat. No. P-I037-006CAS 2699828-16-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.